‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on Covid-19
The CEO of a global pharmaceutical company’s operations in Italy has advice for anyone expecting a Covid-19 solution anytime soon: Drugs and vaccines take time to create — and to be sure they work safely.
“Drug development is a long, long, long process,” Massimo Scaccabarozzi, CEO of Johnson & Johnson’s Janssen unit based in Milan, said Thursday on a call organized by the U.S. public relations firm Spectrum Science. He also heads the pharma industry’s trade association in Italy. “When we speak about a novel drug, if we discover a drug today, it will be in the house of a patient or in the hospital in 10 years.”
